Afib investors have opportunity to lead acutus medical, inc. securities fraud lawsuit

Los angeles, march 14, 2022 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against acutus medical, inc. ("acutus" or the "company") (nasdaq: afib). class period: may 13, 2021 – november 11, 2021 lead plaintiff deadline: april 18, 2022 if you wish to serve as lead plaintiff of the acutus lawsuit, you can submit your contact information at www.glancylaw.com/cases/acutus-medical-inc/.
AFIB Ratings Summary
AFIB Quant Ranking